Enantia is a company devoted to chemical research and process development, custom synthesis and crystal engineering, with a strong focus on asymmetric chemistry and co-crystallisation technologies.
Our mission is to provide fully integrated chemistry services for the fine chemical, pharmaceutical and biotech sectors. We can contribute all the way from initial research in medicinal chemistry or route scouting to any phase of the chemical process R&D. We like to be seen not only as a mere service provider, but as a committed team to pursue the success of our clients' projects.
We can handle almost any kind of chemical project related to organic chemistry, both from a technical and project management point of view. Our chemistry expertise has an industry-leading reputation. The most challenging projects are our day-to-day routine.
Enantia's staff has extensive experience in chemical research and process development and has created a number of chemical processes running today at industrial scale. Clients seeking to improve troublesome steps in a process, or to redesign an entire chemical route for one of their potential APIs or key intermediates, will value the team at Enantia. Our goal is to develop for our clients scalable chemical processes that are safe, environmentally sound, robust and cost-effective. We can contribute to:
We are able to rapidly satisfy custom synthesis requests from mg up to kilo-lab scale in-house, such as the synthesis of:
If you need to produce kilograms or tons of an API or intermediate Enantia can help you, taking care of the production through a network of validated manufacturing partners, both cGMP and non-cGMP.
Co-crystal solid forms are gaining increased significance in the pharmaceutical and chemical industry as an efficient way to modify the physicochemical properties of organic molecules like APIs, intermediates and other synthetic products.
The big advantage of co-crystals compared with salts is that co-crystallisation is also applicable to non-ionisable molecules where salt formation is not possible.
Co-crystals offer great potential in various fields:
Today, with over 40 employees, Enantia has become a reference provider for life sciences companies that seek not only scientific and technical excellence but also a simple and candid way to do business.
With a flexible commercial model, we can execute projects through full time equivalent (FTE) service agreements and also through a variety of different approaches such as fee-per-success, fee-per-project or through a shared risk approach. Flexibility and adaptability to our clients' demands is one of our key assets.
After the signature of a CDA, a free pre-assessment of the project is always carried out and we will only accept projects where we perceive a realistic probability of success.